Effects of 5HT-1A agonists on locomotor and investigatory behaviors in rats differ from those of hallucinogens.
S M Mittman, Mark A. Geyer
Psychopharmacology 1989 DOI: 10.1007/bf00451682 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Preclinical experimental study Peer reviewed |
|---|---|
| Population | Rats |
| Interventions | 8OHDPAT buspirone gepirone ipsapirone d l-propranolol LSD DOM |
| Duration | 1-h test session |
| Measures | Behavioral Pattern Monitor |
| Key findings | The 5HT-1A agonists 8OHDPAT, buspirone, gepirone, and ipsapirone dose-dependently decreased horizontal locomotion and investigatory activity in rats, mainly in the first half of the 1-hour session. Propranolol blocked the effects of ipsapirone and buspirone but only partially antagonized LSD, which the authors argue supports the view that LSD's behavioral effects involve activation of both 5HT-1 and 5HT-2 receptors. |
Abstract
Behavioral profiles composed of both locomotor activity and investigatory behavior were established for the 5HT-1A agonists 8OHDPAT, buspirone, gepirone, and ipsapirone using rats tested in a Behavioral Pattern Monitor. Typically these compounds dose-relatedly decreased horizontal locomotion and investigatory activity during the first half of the 1-h test session. Time-course studies revealed that the time interval between injection and placement of the animal in the testing chamber made no difference in the temporal distribution of locomotor activity following most 5HT-1A agonists. These results were compared and contrasted to the behavioral profiles previously established for hallucinogenic compounds such as LSD and DOM, the psychoactive properties of which have been suggested to be mediated by 5HT-2 binding sites. Examination of ipsapirone and 8OHDPAT in a familiar environment paradigm revealed that both drugs decreased behavioral responding independently of the animals' familiarity with the test environment, in contrast to the behaviorally suppressive effects of hallucinogenic 5HT-2 antagonists which disappear in a familiar environment. Additionally, d,l-propranolol was used as a 5HT-1 antagonist and was found to block the behavioral effects of the 5HT-1A agonists ipsapirone and buspirone without having significant effects by itself. Propranolol was also used to identify the contribution of the 5HT-1 binding site to the behavioral effects of LSD. Even at relatively high doses, propranolol only partially antagonized the effects of LSD, supporting the hypothesis that the behavioral effects of LSD reflect the activation of both 5HT-1 and 5HT-2 receptors.(ABSTRACT TRUNCATED AT 250 WORDS)
Citations in the library
Cited by 11
- Effect of Hallucinogens on Unconditioned Behavior Current Topics in Behavioral Neurosciences 2016
- 5HT-2 mediation of acute behavioral effects of hallucinogens in rats Psychopharmacology March 1, 1990
- Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors. Psychopharmacology November 1, 2008
- Lysergic Acid Diethylamide (LSD) for the Treatment of Anxiety Disorders: Preclinical and Clinical Evidence. CNS Drugs September 1, 2023
- Recent advances in the neuropsychopharmacology of serotonergic hallucinogens. Behavioural Brain Research July 15, 2014
and 6 more in the library
Cites 7
- Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sciences December 17, 1984
- Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis. Journal of Pharmacology and Experimental Therapeutics September 1, 1988
- Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens. Psychopharmacology 1988
- Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens. European Journal of Pharmacology 1988
- Effects of DOM and DMT in a proposed animal model of hallucinogenic activity. Progress in Neuro-Psychopharmacology and Biological Psychiatry 1985
and 2 more in the library